• 13 December 2017

Bioiberica to participate in the 7th Workshop on the Characterization of Heparin Products in London

This is a key meeting in the pharmaceutical industry, in which monographs and heparin quality issues are discussed

Bioiberica focuses on the research, production and sales of this pharmaceutical active ingredient, thus guaranteeing a highly purified and safe product

See all news
Bioiberica to participate in the 7th Workshop on the Characterization of Heparin Products in London

Bioiberica will attend this week to the workshop jointly organized in London by the National Institute for Biological Standards and Control (NIBSC) and the United States Pharmacopeia (USP).

This event, the largest directed exclusively towards heparin, will center on issues dealing of current international level pharmacopeia monographs and quality attributes of heparin products. The different sessions dealt with various themes: from regulatory norms to characteristics of low molecular weight heparins, among others.

Bioiberica will attend this meeting as a producer of pharmaceutical grade active ingredients, as well as a driving force promoting the research and scientific development of heparin. This biotech firm is a world leader in the production of heparin, and its portfolio of products includes sodium heparin, lithium heparin, ammonium heparin, dermatan sulfate, and heparinoids. 

Other news from Heparin

View all news from Heparin